On 22 May 2023, policymakers, thought leaders, Permanent Mission Representatives to the UN, WHO staff, and people affected by liver disease will gather at the EASL Office in Geneva for the invitation-only event on the side-lines of the 76th World Health Assembly*: “Together for Better Liver Health: Mobilising Action for Fatty Liver Disease”. The aim of the event is to raise awareness on the need for action, and to call for a coordinated response to combat the global public health threat represented by fatty liver disease.

Fatty liver disease is the most prevalent liver disease in history, affecting over one in three adults globally and 10% of children. If left unchecked, it can progress to cirrhosis and liver cancer. Despite its prevalence, fatty liver disease remains largely unknown, and its burden is expected to grow further in the years ahead.

The episode showcases the collective effort of global stakeholders who stand united to advocate that fatty liver diseases are included in national and global policies. Our moderator, EASL Vice-Secretary Prof. Aleksander Krag, is joined by distinguished faculty members representing organisations from around the world.

Don’t miss this opportunity to learn about the strategies being put in place to promote liver health and the urgent need for coordinated approaches. Participate in this call for action to address fatty liver disease as a critical step toward a healthier future for all.

*The World Health Assembly is held annually and is an occasion for all WHO member delegations to discuss and make strides on global health issues. The EASL event builds upon WHA76 agenda item 11.2 which includes discussions on policy options and cost-effective interventions for the prevention and control of noncommunicable disease (NCDs). By raising the profile of fatty liver disease, the EASL’s event on the side-lines of the WHA and the publicly accessible EASL Studio special episode can help to catalyse action and improve liver health outcomes worldwide.

Faculty

• Prof. Aleksander Krag (Moderator)
• Prof. Ajay Duseja (Faculty)
• Prof. Manal El-Sayed (Faculty)
• Mr. Marko Korenjak (Faculty)
• Prof. Mario Pessoa (Faculty)
• Prof. Mary E. Rinella (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

Hepatitis D is the most severe form of viral hepatitis infection, but fortunately, new treatments are on the horizon.

This EASL Studio discusses:

• Which patients should be treated.
• Currently available treatment options.
• Treatment combinations and duration.
• New treatments in development.

Faculty

• Prof. Heiner Wedemeyer (Moderator)
• Prof. Soo Aleman (Faculty)
• Prof. Pietro Lampertico (Faculty)

Related episodes:

• S2E3: Interview with Stephan Urban – From bench to bedside: Process of developing the first HBV/HDV entry inhibitor.
• S2E8: Treatment of HBV-HDV coinfection in the era of entry inhibition.
• Midday Talks: HBV and HDV drug development – Where do we stand and where are we going?

All EASL Studio Podcasts are available on EASL Campus.

International Nurses Day, 12 May, commemorates the birth of Florence Nightingale, considered to be the founder of modern nursing.

EASL Studio is taking this opportunity to highlight the important role of nursing in the care of people with liver disease.

Faculty

• Dr Kathryn Jack (Moderator)
• Mrs Michelle Clayton (Faculty)
• Mrs Núria Fabrellas (Faculty)
• Mrs Denise Schäfer (Faculty)
• Dr Patrizia Künzler-Heule (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

Although a longstanding recommendation, the use of albumin as an effective treatment for patients with cirrhosis and ascites has come under scrutiny with recently published studies creating confusion.

This EASL Studio discusses, recent results from the MACHT, ATTIRE and PRECIOSA studies and try to shed some light on this controversial topic.

Faculty

• Prof. Alastair O’Brien (Moderator)
• Prof. Aleksander Krag (Moderator)
• Prof. Paolo Caraceni (Faculty)
• Dr Elisa Pose (Faculty)
• Prof. Joan Clària (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

Watch this EASL Studio for highlights from the Liver Cancer Summit 2023.

Discover:

• How artificial Intelligence is being used to increase knowledge in the field of liver cancer.
• New markers in hepatocellular carcinoma beyond ultrasound.
• Updates in the field cholangiocarcinoma and rare liver diseases
• … and much more!

Faculty

• Prof. Mathias Heikenwälder (Moderator)
• Prof. Josep Llovet (Faculty)
• Prof. Helen Reeves (Faculty)

Related episodes:

• S3E16 – Liver cancer in 2022: Wrap-up & outlook
• S2E15 – JHEP Live – The best animal model for HCC — lost in translation
• Special Edition: Highlights of the Liver Cancer Summit 2022
• Policy Dialogues Episode 3: Liver Cancer: The risk of ignorance

All EASL Studio Podcasts are available on EASL Campus.

Wilson’s disease is a rare autosomal recessive disorder of copper metabolism which is characterised by hepatic and neurological disease

This episode of EASL Studio will:

• Cover the difficulties in diagnosing Wilson’s disease.
• Discuss treatment options and strategies.
• Explore the challenges faced by patients with Wilson’s disease.

Faculty

• Prof. Emmanuel Tsochatzis (Moderator)
• Dr Wiebke Papenthin (Patient Perspective)
• Dr Aurélia Poujois (Faculty)
• Prof. Piotr Socha (Faculty)

Related episodes:

• S4E7 – Genetics in adult liver disease – missed opportunities?
• S3E10 – Cholestatic pruritus: Can the itch be ditched?

All EASL Studio Podcasts are available on EASL Campus.

The EASL Policy Statement on liver cancer screening has recently been updated.

In addition to addressing the updates, this episode of EASL Studio will discuss how risk-based surveillance of hepatocellular carcinoma (HCC) in patients suffering from cirrhosis is a cost effective strategy to increase benefits, reduce the harm of HCC surveillance.

Faculty

• Prof. Thomas Berg (Moderator)
• Mr. Pietro Fiocchi (Faculty)
• Prof. Peter Jepsen (Faculty)
• Mrs. José Willemse (Patient Perspective) 

All EASL Studio Podcasts are available on EASL Campus.

Through widespread multidisciplinary collaboration, consortia and EU grants provide unique opportunities to address critical questions.

• What opportunities exist for early career scientist?
• Which elements are essential for success?
• How have these partnerships contributed to advancements in the field?

Watch this episode of EASL Studio to find out.

Faculty

• Prof. Thomas Berg (Moderator)
• Prof. Rajiv Jalan (Moderator)
• Prof. Minneke Coenraad (Faculty)
• Dr Cornelius Engelmann (Faculty)
• Prof. Pierre-Emmanuel Rautou (Faculty)

Related episode

• S4E2 YI Choice: How to build consortia and registries

All EASL Studio Podcasts are available on EASL Campus.

The topic of liver transplantation for alcohol-related hepatitis is controversial. While some experts still recommend 6 months of alcohol abstinence before considering transplantation others advocate for early transplantation.

Watch this episode to:

• Understand the epidemiology of alcohol-related hepatitis.
• Know which treatment options are available to these patients
• Find out which patients may benefit from earl liver transplantation.

Faculty

• Prof. Patrizia Burra (Moderator)
• Dr Giacomo Germani (Faculty)
• Prof. Alexandre Louvet (Faculty)

Related episodes

• S4E6 – Regenerating the liver graft with a machine
• S3E5 – JHEP Live: Stigma and alcohol

All EASL Studio Podcasts are available on EASL Campus.

Liver biopsy has long been the gold standard for diagnosing NAFLD and NASH. However, it is an invasive  procedure that may not always be necessary. This episode of EASL Studio explored methods for screening, staging, and monitoring disease progression.

Faculty

• Prof. Philip Newsome (Moderator)
• Prof. Laurent Castera (Faculty)
• Prof. Maja Thiele (Faculty)

All EASL Studio Podcasts are available on EASL Campus.